Equities Research Analysts’ Updated EPS Estimates for September, 6th (AAPL, ABX, AKS, ALNY, BLDP, CLF, ERJ, EVH, FRAN, GILD)

Equities Research Analysts’ updated eps estimates for Wednesday, September 6th:

Apple (NASDAQ:AAPL) had its outperform rating reiterated by analysts at Sanford C. Bernstein. Sanford C. Bernstein currently has a $175.00 price target on the stock.

Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at Instinet. They currently have a $185.00 price target on the stock, up from their previous price target of $175.00.

Barrick Gold Corporation (NYSE:ABX) (TSE:ABX) had its buy rating reiterated by analysts at Citigroup Inc..

AK Steel Holding Corporation (NYSE:AKS) had its buy rating reaffirmed by analysts at Bank of America Corporation. Bank of America Corporation currently has a $9.00 target price on the stock.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its outperform rating reiterated by analysts at BMO Capital Markets. The firm currently has a $105.00 target price on the stock.

Ballard Power Systems (NASDAQ:BLDP) (TSE:BLD) had its buy rating reiterated by analysts at FBR & Co.

Cliffs Natural Resources (NYSE:CLF) had its buy rating reiterated by analysts at FBR & Co. FBR & Co currently has a $10.00 target price on the stock. The analysts wrote, “In June, Cleveland-Cliffs announced that it had selected Toledo, Ohio, as the site for its first hot briquetted iron (HBI) facility. We revisit the project economics with updated input prices and provide a sensitivity analysis considering volatile commodity markets. We are also switching our iron ore feedstock cost assumption to market prices (from Cliffs’ production costs previously). At market, we still derive an attractive pretax IRR of 24%, down slightly from ~25% previously on a comparable basis. The modest change is due to a rise in USIO prices, the largest determining factor in HBI’s cost structure. Slightly compensating for the increase in domestic iron ore prices was a gain in scrap metal prices, a signal of an improved HBI market. The scenario analysis bodes well for Cliffs, which we believe backs the company’s claim of a highly attractive growth project.””

Embraer-Empresa Brasileira de Aeronautica (NYSE:ERJ) had its hold rating reissued by analysts at Cowen and Company. They currently have a $24.00 price target on the stock. The analysts wrote, “ERJ’s order for 25 E175’s from SkyWest reinforces its 2018 delivery skyline, reducing.””

Evolent Health (NYSE:EVH) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $28.00 price target on the stock.

Francesca’s Holdings Corporation (NASDAQ:FRAN) had its hold rating reaffirmed by analysts at FBR & Co.

Gilead Sciences (NASDAQ:GILD) had its buy rating reissued by analysts at Berenberg Bank. They currently have a $96.00 price target on the stock, up from their previous price target of $86.00.

Halliburton (NYSE:HAL) had its outperform rating reissued by analysts at Sanford C. Bernstein. The firm currently has a $53.00 target price on the stock.

Himax Technologies (NASDAQ:HIMX) had its outperform rating reiterated by analysts at Macquarie. The firm currently has a $12.20 price target on the stock, up from their previous price target of $11.00.

Helmerich & Payne (NYSE:HP) had its outperform rating reaffirmed by analysts at Sanford C. Bernstein. The firm currently has a $66.00 target price on the stock.

Hewlett Packard Enterprise (NYSE:HPE) had its hold rating reiterated by analysts at Maxim Group. They currently have a $14.00 target price on the stock, down from their previous target price of $18.00.

Hewlett Packard Enterprise (NYSE:HPE) had its neutral rating reiterated by analysts at J P Morgan Chase & Co. J P Morgan Chase & Co currently has a $14.00 price target on the stock.

Insmed (NASDAQ:INSM) had its positive rating reissued by analysts at Robert W. Baird. The firm currently has a $32.00 target price on the stock, up from their previous target price of $23.00.

Insmed (NASDAQ:INSM) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $43.00 price target on the stock, up from their previous price target of $27.00.

Insmed (NASDAQ:INSM) had its outperform rating reissued by analysts at Cowen and Company. They currently have a $54.00 target price on the stock.

Kroger Company (The) (NYSE:KR) had its neutral rating reissued by analysts at UBS AG. They currently have a $24.00 price target on the stock.

Lumentum Holdings (NASDAQ:LITE) had its strong-buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $80.00 target price on the stock.

Eli Lilly and (NYSE:LLY) had its underperform rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $71.00 price target on the stock, down from their previous price target of $73.00.

Mallinckrodt PLC (NYSE:MNK) had its buy rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $85.00 price target on the stock.

Mallinckrodt PLC (NYSE:MNK) had its buy rating reiterated by analysts at Mizuho. The firm currently has a $70.00 target price on the stock.

Marathon Petroleum Corporation (NYSE:MPC) had its buy rating reiterated by analysts at Jefferies Group LLC. They currently have a $64.00 target price on the stock, down from their previous target price of $65.00.

Micron Technology (NASDAQ:MU) had its overweight rating reiterated by analysts at Morgan Stanley. They currently have a $36.00 target price on the stock.

Micron Technology (NASDAQ:MU) had its outperform rating reiterated by analysts at Credit Suisse Group. Credit Suisse Group currently has a $40.00 price target on the stock.

Micron Technology (NASDAQ:MU) had its buy rating reiterated by analysts at Deutsche Bank AG. The firm currently has a $37.00 price target on the stock.

Nabors Industries (NYSE:NBR) had its outperform rating reiterated by analysts at Sanford C. Bernstein. They currently have a $12.50 target price on the stock.

Nucor Corporation (NYSE:NUE) had its buy rating reaffirmed by analysts at Bank of America Corporation. The firm currently has a $73.00 target price on the stock.

Performance Food Group (NYSE:PFGC) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $33.00 target price on the stock, up from their previous target price of $31.00.

Pretium Resources (NYSE:PVG) (TSE:PVG) had its buy rating reiterated by analysts at Citigroup Inc..

Paypal Holdings (NASDAQ:PYPL) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $61.27 price target on the stock, down from their previous price target of $70.00.

Paypal Holdings (NASDAQ:PYPL) had its buy rating reiterated by analysts at BTIG Research. They currently have a $70.00 target price on the stock, up from their previous target price of $63.00.

QUALCOMM (NASDAQ:QCOM) had its overweight rating reissued by analysts at J P Morgan Chase & Co.

Qorvo (NASDAQ:QRVO) had its neutral rating reissued by analysts at Instinet. The firm currently has a $75.00 target price on the stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its outperform rating reissued by analysts at Raymond James Financial, Inc.. Raymond James Financial, Inc. currently has a $566.00 price target on the stock.

Schlumberger N.V. (NYSE:SLB) had its outperform rating reissued by analysts at Sanford C. Bernstein. The firm currently has a $80.00 target price on the stock.

Snap (NYSE:SNAP) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $15.00 target price on the stock.

Skyworks Solutions (NASDAQ:SWKS) had its buy rating reaffirmed by analysts at Instinet. Instinet currently has a $115.00 target price on the stock.

United Technologies Corporation (NYSE:UTX) had its buy rating reissued by analysts at Bank of America Corporation. The firm currently has a $140.00 target price on the stock.